Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-10-01

AUTHORS

Y Saga, H Mizukami, M Suzuki, M Urabe, A Kume, T Nakamura, I Sato, K Ozawa

ABSTRACT

Peritoneal dissemination is the most frequent progression pathway of ovarian cancer and is therefore a key step to improve the prognosis. NK4, a large part of the α-chain of hepatocyte growth factor, is known to inhibit cancer cell migration. To characterize the function of NK4 and investigate its potential role in gene therapy of ovarian cancer, we introduced NK4 cDNA to an ovarian cancer cell line HRA and investigated its effects both in vitro and in vivo. HRA cells were transfected with either NK4 or luciferase-expression plasmids. After selection, NK4-expressing HRA cells (HRA/NK4) and the control cells (HRA/LUC) were obtained. NK4 was detected in the culture supernatant of HRA/NK4 by Western analysis. Migration capabilities of the cells were evaluated in vitro by scratch wound healing assay. The number of migrated cells was significantly smaller in the HRA/NK4 cultures than that in the control cultures (HRA or HRA/LUC). Also, the culture supernatant of HRA/NK4 significantly suppressed migration of control cells. This suppressive effect was observed when NK4-expressing cells were mixed with control cells at the ratio of 25% or more. In the in vivo experiments, HRA transfectants were injected intraperitoneally. The number of intraperitoneal tumors of HRA/NK4 was much smaller than that of control. In mice injected with HRA/NK4, ascites formation was suppressed and the survival was significantly prolonged. These findings suggest that NK4-mediated gene therapy can improve the prognosis of ovarian cancer by suppressing peritoneal dissemination. Gene Therapy (2001) 8, 1450–1455. More... »

PAGES

1450-1455

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.gt.3301553

DOI

http://dx.doi.org/10.1038/sj.gt.3301553

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009223294

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11593357


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatocyte Growth Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitogens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Invasiveness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ovarian Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Statistics, Nonparametric", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Department of Obstetrics and Gynecology, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan", 
            "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saga", 
        "givenName": "Y", 
        "id": "sg:person.0611710645.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611710645.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mizukami", 
        "givenName": "H", 
        "id": "sg:person.0613664001.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613664001.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Obstetrics and Gynecology, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Department of Obstetrics and Gynecology, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "M", 
        "id": "sg:person.013750020764.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013750020764.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Urabe", 
        "givenName": "M", 
        "id": "sg:person.01337270101.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337270101.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kume", 
        "givenName": "A", 
        "id": "sg:person.0672430713.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672430713.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Biochemistry, Department of Oncology, Biomedical Research Center, Osaka University Medical School, Suita, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Division of Biochemistry, Department of Oncology, Biomedical Research Center, Osaka University Medical School, Suita, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakamura", 
        "givenName": "T", 
        "id": "sg:person.016713015034.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016713015034.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Obstetrics and Gynecology, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Department of Obstetrics and Gynecology, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "I", 
        "id": "sg:person.010620036154.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010620036154.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ozawa", 
        "givenName": "K", 
        "id": "sg:person.013136320052.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013136320052.97"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/342440a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009687593", 
          "https://doi.org/10.1038/342440a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006348317841", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004186226", 
          "https://doi.org/10.1023/a:1006348317841"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/73464", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023348153", 
          "https://doi.org/10.1038/73464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/7895", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019648001", 
          "https://doi.org/10.1038/7895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cgt.7700147", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052055441", 
          "https://doi.org/10.1038/sj.cgt.7700147"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/227680a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010419937", 
          "https://doi.org/10.1038/227680a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1202231", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036312697", 
          "https://doi.org/10.1038/sj.onc.1202231"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-10-01", 
    "datePublishedReg": "2001-10-01", 
    "description": "Peritoneal dissemination is the most frequent progression pathway of ovarian cancer and is therefore a key step to improve the prognosis. NK4, a large part of the \u03b1-chain of hepatocyte growth factor, is known to inhibit cancer cell migration. To characterize the function of NK4 and investigate its potential role in gene therapy of ovarian cancer, we introduced NK4 cDNA to an ovarian cancer cell line HRA and investigated its effects both in vitro and in vivo. HRA cells were transfected with either NK4 or luciferase-expression plasmids. After selection, NK4-expressing HRA cells (HRA/NK4) and the control cells (HRA/LUC) were obtained. NK4 was detected in the culture supernatant of HRA/NK4 by Western analysis. Migration capabilities of the cells were evaluated in vitro by scratch wound healing assay. The number of migrated cells was significantly smaller in the HRA/NK4 cultures than that in the control cultures (HRA or HRA/LUC). Also, the culture supernatant of HRA/NK4 significantly suppressed migration of control cells. This suppressive effect was observed when NK4-expressing cells were mixed with control cells at the ratio of 25% or more. In the in vivo experiments, HRA transfectants were injected intraperitoneally. The number of intraperitoneal tumors of HRA/NK4 was much smaller than that of control. In mice injected with HRA/NK4, ascites formation was suppressed and the survival was significantly prolonged. These findings suggest that NK4-mediated gene therapy can improve the prognosis of ovarian cancer by suppressing peritoneal dissemination. Gene Therapy (2001) 8, 1450\u20131455.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.gt.3301553", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105638", 
        "issn": [
          "0969-7128", 
          "1476-5462"
        ], 
        "name": "Gene Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "19", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "ovarian cancer", 
      "peritoneal dissemination", 
      "HRA cells", 
      "control cells", 
      "ovarian cancer cells", 
      "culture supernatants", 
      "HGF/NK4", 
      "hepatocyte growth factor", 
      "cancer cell migration", 
      "gene therapy", 
      "scratch wound healing", 
      "intraperitoneal tumors", 
      "intraperitoneal dissemination", 
      "suppressive effect", 
      "NK4 cDNA", 
      "NK4", 
      "growth factor", 
      "cancer cells", 
      "host survival", 
      "cancer", 
      "wound healing", 
      "potential role", 
      "prognosis", 
      "luciferase expression plasmid", 
      "vivo experiments", 
      "progression pathways", 
      "therapy", 
      "cell migration", 
      "migration capability", 
      "Western analysis", 
      "survival", 
      "\u03b1-chain", 
      "control cultures", 
      "cells", 
      "supernatant", 
      "dissemination", 
      "tumors", 
      "mice", 
      "healing", 
      "vivo", 
      "transfectants", 
      "effect", 
      "migration", 
      "expression", 
      "HRA", 
      "culture", 
      "pathway", 
      "findings", 
      "factors", 
      "control", 
      "number", 
      "role", 
      "plasmid", 
      "cDNA", 
      "large part", 
      "function", 
      "ratio", 
      "analysis", 
      "part", 
      "key step", 
      "selection", 
      "formation", 
      "step", 
      "experiments", 
      "capability"
    ], 
    "name": "Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival", 
    "pagination": "1450-1455", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009223294"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.gt.3301553"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11593357"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.gt.3301553", 
      "https://app.dimensions.ai/details/publication/pub.1009223294"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_344.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.gt.3301553"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301553'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301553'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301553'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.gt.3301553'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      21 PREDICATES      112 URIs      97 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.gt.3301553 schema:about N038c01f19c044fce8624ac74ba091aa6
2 N0b33bd61c8dd4451a1fc1b97446b059b
3 N158723d12e684495ac42441138f0a65b
4 N3df3dc46723b4ebfbfd3561e2257fada
5 N4b08493b04964e0aaa4acee21bbd450d
6 N4c51a04b8430403c9a12e17c819aae0c
7 N4efd2045ed3141ab81e7ad6df5d84cd9
8 N6697b3ab073a403aac5361cd372aa390
9 N791d60b8ac5f4accb58d4c9f0f2b864f
10 Na1156e0f549d46929a3a2a5de57cd8ae
11 Naa790c095ced432385d4097cb39f35bc
12 Nac6edd26ff65477c9025f5ede88ffbcf
13 Ncec08b1d05c34ec584d4cf14f5f5ead3
14 Nd7cdfe862b9a496da68d7bc67dd867ee
15 Ne533909715c0424393029df69f580a32
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author N93457f6f95474fbda7adf14b2d5a8e26
19 schema:citation sg:pub.10.1023/a:1006348317841
20 sg:pub.10.1038/227680a0
21 sg:pub.10.1038/342440a0
22 sg:pub.10.1038/73464
23 sg:pub.10.1038/7895
24 sg:pub.10.1038/sj.cgt.7700147
25 sg:pub.10.1038/sj.onc.1202231
26 schema:datePublished 2001-10-01
27 schema:datePublishedReg 2001-10-01
28 schema:description Peritoneal dissemination is the most frequent progression pathway of ovarian cancer and is therefore a key step to improve the prognosis. NK4, a large part of the α-chain of hepatocyte growth factor, is known to inhibit cancer cell migration. To characterize the function of NK4 and investigate its potential role in gene therapy of ovarian cancer, we introduced NK4 cDNA to an ovarian cancer cell line HRA and investigated its effects both in vitro and in vivo. HRA cells were transfected with either NK4 or luciferase-expression plasmids. After selection, NK4-expressing HRA cells (HRA/NK4) and the control cells (HRA/LUC) were obtained. NK4 was detected in the culture supernatant of HRA/NK4 by Western analysis. Migration capabilities of the cells were evaluated in vitro by scratch wound healing assay. The number of migrated cells was significantly smaller in the HRA/NK4 cultures than that in the control cultures (HRA or HRA/LUC). Also, the culture supernatant of HRA/NK4 significantly suppressed migration of control cells. This suppressive effect was observed when NK4-expressing cells were mixed with control cells at the ratio of 25% or more. In the in vivo experiments, HRA transfectants were injected intraperitoneally. The number of intraperitoneal tumors of HRA/NK4 was much smaller than that of control. In mice injected with HRA/NK4, ascites formation was suppressed and the survival was significantly prolonged. These findings suggest that NK4-mediated gene therapy can improve the prognosis of ovarian cancer by suppressing peritoneal dissemination. Gene Therapy (2001) 8, 1450–1455.
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf N90076edc02884495bc940aea8b513ab0
32 Ne499b86a6bc54c778f7fea9a4af4ffde
33 sg:journal.1105638
34 schema:keywords HGF/NK4
35 HRA
36 HRA cells
37 NK4
38 NK4 cDNA
39 Western analysis
40 analysis
41 cDNA
42 cancer
43 cancer cell migration
44 cancer cells
45 capability
46 cell migration
47 cells
48 control
49 control cells
50 control cultures
51 culture
52 culture supernatants
53 dissemination
54 effect
55 experiments
56 expression
57 factors
58 findings
59 formation
60 function
61 gene therapy
62 growth factor
63 healing
64 hepatocyte growth factor
65 host survival
66 intraperitoneal dissemination
67 intraperitoneal tumors
68 key step
69 large part
70 luciferase expression plasmid
71 mice
72 migration
73 migration capability
74 number
75 ovarian cancer
76 ovarian cancer cells
77 part
78 pathway
79 peritoneal dissemination
80 plasmid
81 potential role
82 prognosis
83 progression pathways
84 ratio
85 role
86 scratch wound healing
87 selection
88 step
89 supernatant
90 suppressive effect
91 survival
92 therapy
93 transfectants
94 tumors
95 vivo
96 vivo experiments
97 wound healing
98 α-chain
99 schema:name Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival
100 schema:pagination 1450-1455
101 schema:productId N0eccfda582cf41a4b3ca7a3df059bff2
102 N475b45dc1f9349b0ae61f35177e57e62
103 Nd9e6133341784b9fabada58e4c43c8a7
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009223294
105 https://doi.org/10.1038/sj.gt.3301553
106 schema:sdDatePublished 2022-09-02T15:50
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher Na4d9fd5c43d945aa9a9afe4cca1ad5ff
109 schema:url https://doi.org/10.1038/sj.gt.3301553
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N038c01f19c044fce8624ac74ba091aa6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Humans
115 rdf:type schema:DefinedTerm
116 N0b33bd61c8dd4451a1fc1b97446b059b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Ovarian Neoplasms
118 rdf:type schema:DefinedTerm
119 N0eccfda582cf41a4b3ca7a3df059bff2 schema:name pubmed_id
120 schema:value 11593357
121 rdf:type schema:PropertyValue
122 N158723d12e684495ac42441138f0a65b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Hepatocyte Growth Factor
124 rdf:type schema:DefinedTerm
125 N1a12900ef81643f7af0306d57fad6ab3 rdf:first sg:person.0613664001.27
126 rdf:rest N707d21b687784b1fa0c64a519cd37b3e
127 N1f78963e48284a10896f0178eed347e6 rdf:first sg:person.010620036154.58
128 rdf:rest N2a73e9344f0f4aeea85bcbf77b23eb12
129 N2a73e9344f0f4aeea85bcbf77b23eb12 rdf:first sg:person.013136320052.97
130 rdf:rest rdf:nil
131 N3df3dc46723b4ebfbfd3561e2257fada schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Neoplasms, Experimental
133 rdf:type schema:DefinedTerm
134 N475b45dc1f9349b0ae61f35177e57e62 schema:name doi
135 schema:value 10.1038/sj.gt.3301553
136 rdf:type schema:PropertyValue
137 N4b08493b04964e0aaa4acee21bbd450d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Mice
139 rdf:type schema:DefinedTerm
140 N4c51a04b8430403c9a12e17c819aae0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Tumor Cells, Cultured
142 rdf:type schema:DefinedTerm
143 N4efd2045ed3141ab81e7ad6df5d84cd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Neoplasm Invasiveness
145 rdf:type schema:DefinedTerm
146 N6697b3ab073a403aac5361cd372aa390 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Statistics, Nonparametric
148 rdf:type schema:DefinedTerm
149 N707d21b687784b1fa0c64a519cd37b3e rdf:first sg:person.013750020764.21
150 rdf:rest Nf3b39ae2547141d59362df701781b10f
151 N791d60b8ac5f4accb58d4c9f0f2b864f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Animals
153 rdf:type schema:DefinedTerm
154 N90076edc02884495bc940aea8b513ab0 schema:volumeNumber 8
155 rdf:type schema:PublicationVolume
156 N93457f6f95474fbda7adf14b2d5a8e26 rdf:first sg:person.0611710645.56
157 rdf:rest N1a12900ef81643f7af0306d57fad6ab3
158 Na1156e0f549d46929a3a2a5de57cd8ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Mitogens
160 rdf:type schema:DefinedTerm
161 Na4d9fd5c43d945aa9a9afe4cca1ad5ff schema:name Springer Nature - SN SciGraph project
162 rdf:type schema:Organization
163 Naa790c095ced432385d4097cb39f35bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Gene Expression
165 rdf:type schema:DefinedTerm
166 Nac6edd26ff65477c9025f5ede88ffbcf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Mice, Inbred BALB C
168 rdf:type schema:DefinedTerm
169 Nc1cfd83ae55d4f95ba7dd01b8bff0d48 rdf:first sg:person.0672430713.98
170 rdf:rest Nca87aab619d348158612ef4eeddcb0e2
171 Nca87aab619d348158612ef4eeddcb0e2 rdf:first sg:person.016713015034.99
172 rdf:rest N1f78963e48284a10896f0178eed347e6
173 Ncec08b1d05c34ec584d4cf14f5f5ead3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Female
175 rdf:type schema:DefinedTerm
176 Nd7cdfe862b9a496da68d7bc67dd867ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Genetic Therapy
178 rdf:type schema:DefinedTerm
179 Nd9e6133341784b9fabada58e4c43c8a7 schema:name dimensions_id
180 schema:value pub.1009223294
181 rdf:type schema:PropertyValue
182 Ne499b86a6bc54c778f7fea9a4af4ffde schema:issueNumber 19
183 rdf:type schema:PublicationIssue
184 Ne533909715c0424393029df69f580a32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Survival Rate
186 rdf:type schema:DefinedTerm
187 Nf3b39ae2547141d59362df701781b10f rdf:first sg:person.01337270101.39
188 rdf:rest Nc1cfd83ae55d4f95ba7dd01b8bff0d48
189 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
190 schema:name Medical and Health Sciences
191 rdf:type schema:DefinedTerm
192 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
193 schema:name Oncology and Carcinogenesis
194 rdf:type schema:DefinedTerm
195 sg:journal.1105638 schema:issn 0969-7128
196 1476-5462
197 schema:name Gene Therapy
198 schema:publisher Springer Nature
199 rdf:type schema:Periodical
200 sg:person.010620036154.58 schema:affiliation grid-institutes:grid.410804.9
201 schema:familyName Sato
202 schema:givenName I
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010620036154.58
204 rdf:type schema:Person
205 sg:person.013136320052.97 schema:affiliation grid-institutes:grid.410804.9
206 schema:familyName Ozawa
207 schema:givenName K
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013136320052.97
209 rdf:type schema:Person
210 sg:person.01337270101.39 schema:affiliation grid-institutes:grid.410804.9
211 schema:familyName Urabe
212 schema:givenName M
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337270101.39
214 rdf:type schema:Person
215 sg:person.013750020764.21 schema:affiliation grid-institutes:grid.410804.9
216 schema:familyName Suzuki
217 schema:givenName M
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013750020764.21
219 rdf:type schema:Person
220 sg:person.016713015034.99 schema:affiliation grid-institutes:grid.136593.b
221 schema:familyName Nakamura
222 schema:givenName T
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016713015034.99
224 rdf:type schema:Person
225 sg:person.0611710645.56 schema:affiliation grid-institutes:grid.410804.9
226 schema:familyName Saga
227 schema:givenName Y
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611710645.56
229 rdf:type schema:Person
230 sg:person.0613664001.27 schema:affiliation grid-institutes:grid.410804.9
231 schema:familyName Mizukami
232 schema:givenName H
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613664001.27
234 rdf:type schema:Person
235 sg:person.0672430713.98 schema:affiliation grid-institutes:grid.410804.9
236 schema:familyName Kume
237 schema:givenName A
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672430713.98
239 rdf:type schema:Person
240 sg:pub.10.1023/a:1006348317841 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004186226
241 https://doi.org/10.1023/a:1006348317841
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/227680a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010419937
244 https://doi.org/10.1038/227680a0
245 rdf:type schema:CreativeWork
246 sg:pub.10.1038/342440a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009687593
247 https://doi.org/10.1038/342440a0
248 rdf:type schema:CreativeWork
249 sg:pub.10.1038/73464 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023348153
250 https://doi.org/10.1038/73464
251 rdf:type schema:CreativeWork
252 sg:pub.10.1038/7895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019648001
253 https://doi.org/10.1038/7895
254 rdf:type schema:CreativeWork
255 sg:pub.10.1038/sj.cgt.7700147 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052055441
256 https://doi.org/10.1038/sj.cgt.7700147
257 rdf:type schema:CreativeWork
258 sg:pub.10.1038/sj.onc.1202231 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036312697
259 https://doi.org/10.1038/sj.onc.1202231
260 rdf:type schema:CreativeWork
261 grid-institutes:grid.136593.b schema:alternateName Division of Biochemistry, Department of Oncology, Biomedical Research Center, Osaka University Medical School, Suita, Osaka, Japan
262 schema:name Division of Biochemistry, Department of Oncology, Biomedical Research Center, Osaka University Medical School, Suita, Osaka, Japan
263 rdf:type schema:Organization
264 grid-institutes:grid.410804.9 schema:alternateName Department of Obstetrics and Gynecology, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan
265 Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan
266 schema:name Department of Obstetrics and Gynecology, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan
267 Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Yakushiji, Minamikawachi, Tochigi, Japan
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...